RARA and leukemia: No statistically significant differences were observed for the wild-type SEPT2 expression between the non-MLL-SEPT2 leukemia subgroups and the normal controls, with the exception of the PML-RARA and "normal karyotype" leukemias that showed lower expression (Table 1).